PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Neuropsychobiology

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Neuropsychobiology has 1 tracked paper indexed in Blossom (2004) from 5 authors, most often covering Ayahuasca and DMT, across Neuroimaging & Brain Measures.

Published Papers

Open Accessindividual

Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography

Using LORETA on EEG from 18 volunteers given encapsulated ayahuasca (0.85 mg DMT/kg), the study found significant decreases in alpha‑2, delta, theta and beta‑1 power 60–90 minutes after dosing versus placebo. These reductions were localised to the temporo‑parieto‑occipital junction and temporomedial/frontomedial regions, paralleled increased Hallucinogen Rating Scale scores, and implicate unimodal/heteromodal association cortices and limbic structures in ayahuasca’s psychological effects.

Published
June 11, 2004
Journal
Neuropsychobiology
Authors
Riba, J., Anderer, P., Jané, F., Saletu, B., Barbanoj, M. J.

Quick Facts

Papers Indexed
1
h-Index
95
Open Access
No
Publisher
Karger
Country
Switzerland
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.